1244642-70-3 Usage
Uses
Used in Pharmaceutical Industry:
Methyl 3-bromo-4,5-difluorobenzoate is used as an intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the development of new drugs with improved properties.
Used in Agrochemical Industry:
In the agrochemical field, methyl 3-bromo-4,5-difluorobenzoate serves as a key intermediate in the production of agrochemicals, potentially enhancing the effectiveness of pesticides and other agricultural chemicals.
Used in Organic Chemistry Research:
Methyl 3-bromo-4,5-difluorobenzoate is utilized as a building block in organic chemistry for the creation of various chemicals and materials, thanks to its unique structure that allows for further reactions and modifications.
Used in Chemical Synthesis:
As a valuable compound in chemical synthesis, methyl 3-bromo-4,5-difluorobenzoate is employed to explore new synthetic pathways and develop innovative chemical processes.
Used in Drug Development:
Its role in drug development is significant, as researchers use methyl 3-bromo-4,5-difluorobenzoate to design and test new molecular entities with potential therapeutic applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1244642-70-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,4,4,6,4 and 2 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1244642-70:
(9*1)+(8*2)+(7*4)+(6*4)+(5*6)+(4*4)+(3*2)+(2*7)+(1*0)=143
143 % 10 = 3
So 1244642-70-3 is a valid CAS Registry Number.
1244642-70-3Relevant academic research and scientific papers
1,2,3,5-TETRAHYDROIMIDAZO[1,2-C]PYRIMIDINE DERIVATIVES USEFUL IN THE TREATMENT OF DISEASES AND DISORDERS MEDIATED BY LP-PLA2
-
Page/Page column 35, (2016/02/18)
The present invention relates to novel compounds that inhibit Lp‐PLA2 activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases or disorders associated with the activity of Lp‐PLAs
